FDA Withdraws Approval of 35 New Drug Applications and 64 Abbreviated New Drug Applications from Abbott Laboratories and Other Applicants

Summary

Abbott Laboratories and other applicants are having their 35 new drug applications and 64 abbreviated new drug applications withdrawn by the FDA due to the drugs no longer being marketed. The FDA is removing approval for these applications after applicants notified the agency in writing.